Quantcast

Latest Venous ulcer Stories

2010-11-10 08:53:00

ADDISON, Texas, Nov. 10, 2010 /PRNewswire/ -- ULURU Inc. (NYSE Amex: ULU) today provided a clinical update and summary of recent participation at major wound care conferences. During the past 45 days Altrazeal® has been presented at three major wound care conferences Symposium of Advanced Wound Care ("SAWC") Clinical Symposium on Advances in Skin and Wound Care ("CSASWC") Diabetic Limb Salvage 2010 ("DLS") Participation in these conferences not only benefit our...

2010-09-28 11:15:00

CANTON, Mass., Sept. 28 /PRNewswire/ -- Organogenesis, Inc. announced that its Apligraf® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA) of the Kingdom of Saudi Arabia. Apligraf is a living cell based product used by physicians to heal chronic wounds in patients in the U.S. and around the world. "With diabetes being a widespread and growing medical problem...

2010-05-26 16:11:00

ZUG, Switzerland and CANTON, Mass., May 26 /PRNewswire/ -- Organogenesis Switzerland GmbH will sponsor a symposium on Apligraf®, a bilayered living cellular construct for the treatment of chronic wounds and soft tissue repair, at the upcoming European Wound Management Association (EWMA) conference. This will be the first symposium ever held in Europe on the use of an allogeneic living cellular construct in the treatment of chronic wounds. At the symposium, titled...

2010-05-25 07:30:00

SAN DIEGO, May 25 /PRNewswire/ -- CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a...

2010-04-08 07:00:00

ADDISON, Texas, April 8 /PRNewswire-FirstCall/ --ULURU Inc. (NYSE Amex: ULU) announced today that the Company will be presenting clinical data at the 2010 American Professional Wound Care Association(APWCA) National Conference in Philadelphia, PA April 8-11, 2010. At the conference, Altrazeal(TM) clinical evidence, best clinical practices, and advanced clinical applications will be showcased in both podium and poster presentations. Dr. Gregory Bohn, MD, FACS, Medical Director of the...

2010-03-23 09:34:00

ADDISON, Texas, March 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) announced that it sponsored a Wound Dressing Workshop at the 2010 Diabetic Foot Global Conference. Attendees of the Diabetic Foot Global Conference (DFCon) in Hollywood, California on March 20, 2010 participated in a hands-on workshop where they were trained in "best clinical practice" for Altrazeal(TM). Participants learned application techniques, clinical endpoints, and methods for treating different wound...

2010-02-18 12:22:00

BOSTON, Feb. 18 /PRNewswire/ -- TEI Biosciences Inc. announced today that its PriMatrix(TM) Dermal Repair Scaffold has been awarded the coveted American Podiatric Medical Association's (APMA) Seal of Approval. PriMatrix is a bioactive collagen matrix used in the management of diabetic and venous ulcers, second-degree burns, and surgical and trauma wounds. APMA is the nation's leading professional society for foot and ankle specialists. The Seal of Approval Program was created to inform...

2010-02-11 07:00:00

ROCKVILLE, Md., Feb. 11 /PRNewswire/ -- Glycotex, Inc. today announced the expansion of its patent portfolio in Advanced Wound Healing for its product candidate GLYC-101 currently in clinical phase 2 in the United States. On January 19, 2010 US Patent No. 7,648,968 issued with claims directed to the use of microparticulate glucan including GLYC-101 for the treatment of dermal ulcers. The grant of this US patent represents a significant development in Glycotex's US patent portfolio as it...

2010-01-13 18:35:00

FORT WORTH, Texas, Jan. 13 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it is nearing the completion of its registration of CellerateRX in Mexico and has identified its first distributor in that country. Numerous physicians in the nation have already evaluated the Activated Collagen wound care product and were impressed with its speed and efficacy in the management of diabetic ulcers and are optimistic that it will play a...

2009-12-22 08:17:00

RICHMOND, Virginia and ROSH HA'AYIN, Israel, December 22 /PRNewswire/ -- EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for advanced chronic wound management, announced today that it successfully completed its latest round of funding of US $2.5 million. The round was led by Eli Gilboa, CPA, of Gilboa & Licht, who serves as the company's active chairman at a company valuation of US$18.5 million. To date, the company has raised a total US$10 million. Proceeds will be...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.